BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29189509)

  • 21. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia.
    Heilmann AM; Schrock AB; He J; Nahas M; Curran K; Shukla N; Cramer S; Draper L; Verma A; Erlich R; Ross J; Stephens P; Miller VA; Ali SM; Verglio JA; Tallman MS; Mughal TI
    Leukemia; 2017 Sep; 31(9):1989-1992. PubMed ID: 28552906
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bilateral leukemic optic nerve infiltration as the first manifestation of extramedullary relapse in T-cell acute lymphoblastic leukemia].
    Amer R; David R; Dotan S
    Harefuah; 2013 Feb; 152(2):112-4, 121. PubMed ID: 23513505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.
    Huh JY; Chung S; Oh D; Kang MS; Eom HS; Cho EH; Han MH; Kong SY
    Korean J Lab Med; 2010 Apr; 30(2):117-21. PubMed ID: 20445327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia.
    Khater F; Lajoie M; Langlois S; Healy J; Cellot S; Richer C; Beaulieu P; St-Onge P; Saillour V; Minden M; Marzouki M; Krajinovic M; Bittencourt H; Sinnett D
    Blood; 2017 Mar; 129(12):1729-1732. PubMed ID: 28069604
    [No Abstract]   [Full Text] [Related]  

  • 26. Relapsed T-cell acute lymphoblastic leukaemia in the vitreous of an adult: a case report.
    Allchin R; Pradeep A; Sheard R; Rennie IG; Mudhar HS
    Eye (Lond); 2014 Aug; 28(8):1035-6. PubMed ID: 24810574
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.
    Mark C; Meshinchi S; Joyce B; Gibson B; Harrison C; Bergmann AK; Goemans BF; Pronk CJH; Lapillonne H; Leverger G; Antoniou E; Schneider M; Attarbaschi A; Dworzak M; Stary J; Tomizawa D; Ebert S; Lejman M; Kolb EA; Schmiegelow K; Hasle H; Abla O
    Br J Haematol; 2024 Feb; 204(2):576-584. PubMed ID: 37743097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.
    Abla O; Ries RE; Triche T; Gerbing RB; Hirsch B; Raimondi S; Cooper T; Farrar JE; Buteyn N; Harmon LM; Wen H; Deshpande AJ; Kolb EA; Gamis AS; Aplenc R; Alonzo T; Meshinchi S
    Blood Adv; 2024 Apr; 8(8):2005-2017. PubMed ID: 38306602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MLLT10 and IL3 rearrangement together with a complex four-way translocation and trisomy 4 in a patient with early T-cell precursor acute lymphoblastic leukemia: A case report.
    Othman MA; Melo JB; Carreira IM; Rincic M; Alhourani E; Wilhelm K; Gruhn B; Glaser A; Liehr T
    Oncol Rep; 2015 Feb; 33(2):625-30. PubMed ID: 25435396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular monitoring in NUP214-ABL-positive T-acute lymphoblastic leukemia reveals clonal diversity and helps to guide targeted therapy.
    Koschmieder S; Burmeister T; Brüggemann M; Berkemeier A; Volpert S; Wieacker P; Silling G; Gökbuget N; Müller-Tidow C; Berdel WE; Stelljes M
    Leukemia; 2014 Feb; 28(2):419-22. PubMed ID: 24048416
    [No Abstract]   [Full Text] [Related]  

  • 31. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
    Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse.
    Clarke S; O'Reilly J; Romeo G; Cooney J
    Leuk Res; 2011 Jul; 35(7):e131-3. PubMed ID: 21489623
    [No Abstract]   [Full Text] [Related]  

  • 33. Whole-exome sequencing reveals the subclonal expression of NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.
    Tsurusaki Y; Nagai JI; Fujita S; Sugiyama M; Nakamura W; Hayashi A; Miyagawa N; Keino D; Yokosuka T; Iwasaki F; Hamanoue S; Shiomi M; Goto S; Kurosawa K; Goto H
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28019. PubMed ID: 31556219
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Wofford MM; Smith SD; Shuster JJ; Johnson W; Buchanan GR; Wharam MD; Ritchey AK; Rosen D; Haggard ME; Golembe BL
    J Clin Oncol; 1992 Apr; 10(4):624-30. PubMed ID: 1548525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NAP1L1-MLLT10 is a rare recurrent translocation that is associated with HOXA activation and poor treatment response in T-cell acute lymphoblastic leukaemia.
    Bond J; Touzart A; Cieslak A; Trinquand A; Marchand T; Escoffre M; Contet A; Muller M; Schmitt C; Fest T; Asnafi V; Macintyre E
    Br J Haematol; 2016 Aug; 174(3):470-3. PubMed ID: 26455581
    [No Abstract]   [Full Text] [Related]  

  • 36. Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
    Uckun FM; Gaynon PS; Stram DO; Sensel MG; Sarquis MB; Willoughby M
    Leuk Lymphoma; 2001 Jan; 40(3-4):279-85. PubMed ID: 11426549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRD analysis and treatment outcome in three children with SET-NUP214-positive hematological malignancies.
    Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xing YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
    Int J Lab Hematol; 2011 Dec; 33(6):e25-7. PubMed ID: 21679311
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
    Einsiedel HG; von Stackelberg A; Hartmann R; Fengler R; Schrappe M; Janka-Schaub G; Mann G; Hählen K; Göbel U; Klingebiel T; Ludwig WD; Henze G
    J Clin Oncol; 2005 Nov; 23(31):7942-50. PubMed ID: 16258094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of a minor Philadelphia-positive clone in young adults with de novo T-cell ALL.
    Prebet T; Mozziconacci MJ; Sainty D; Arnoulet C; Lafage M; Dastugue N; Charbonnier A; Coso D; Gastaut JA; Blaise D; Vey N
    Leuk Lymphoma; 2009 Mar; 50(3):485-7. PubMed ID: 19197723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.